ArticleFrontiers in veterinary science2025
Assessment of histotripsy as a bone-sparing tumor ablation technique in
Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Histotripsy treatment reduces tumor burden and extends survival in an orthotopic mouse model of osteosarcoma.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Background: Osteosarcoma (OS) is an aggressive primary bone cancer that is highly resistant to conventional therapies. Histotripsy, a non-invasive and non-thermal focused ultrasound ablation technique, has recently been explored as a treatment for OS in a canine comparative anatomy model exhibiting heterogeneous tumor phenotypes. However, the biomechanical effects of histotripsy on OS tumor-bearing bone and adjacent grossly normal bone remain unknown. This study aimed to evaluate the impact of histotripsy on the mechanical properties of bone and to characterize tumor heterogeneity. Methods: Results: No significant differences were detected between ablated and unablated conditions within normal bone or within tumor-affected bone, indicating that histotripsy did not compromise the structural integrity of normal bone nor exacerbate damage in tumor-affected bone. Unablated trabecular tumor specimens exhibited higher and more variable elastic modulus and ultimate strength values than other groups, highlighting tumor heterogeneity. μCT analysis confirmed substantial structural heterogeneity among unablated tumor specimens, particularly in bone volume fraction. Conclusion: Histotripsy preserves the mechanical integrity of both tumor-affected and normal bone. These results support histotripsy's potential as a non-invasive, bone-sparing, patient-specific therapeutic approach for clinical osteosarcoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.